ArticleScientific reports2023

Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care.

Myriam Riek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.